Michał Mielnik

5PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersEmergency medicineMedical mycologyNeurology and neuromuscular diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 25, 2023
The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients.

Michał Mielnik, Aneta Szudy-Szczyrek, Iwona Homa-Mlak

|Feb 25, 2022
SARS-CoV-2 Seroprevalence in Healthcare Workers before the Vaccination in Poland: Evolution from the First to the Second Pandemic Outbreak.

Izabela Korona-Głowniak, Michał Mielnik, Martyna Podgajna

|Feb 25, 2022
Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma.

Aneta Szudy-Szczyrek, Radosław Mlak, Michał Mielnik

|Jun 23, 2020
Serum brain-derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients.

Aneta Szudy-Szczyrek, Radosław Mlak, Magdalena Bury-Kamińska

|Oct 24, 2018
Effectiveness of Haemophilus influenzae type b vaccination after splenectomy - impact on selected immunological parameters.

Ewelina Grywalska, Dorota Siwicka-Gieroba, Michał Mielnik

Pageof 1

Frequent Collaborators

5 joint publications

Martyna Podgajna-Mielnik

3 joint publications

Aneta Szudy-Szczyrek

2 joint publications

Ewelina Grywalska

2 joint publications

Radosław Mlak